FDA restricts use of certain monoclonal antibody treatments that don't work against omicron
32 across the spectrum. Choose a side on the bar to jump to it.
National story. 70 articles from 32 sources. Updated Jan 26, 2022.
Left
9 sourcesThe FDA limits the use of some monoclonal antibodies treatments
FDA Limits Use of Two COVID Antibody Treatments
FDA May Limit Use of Two COVID-19 Antibody Treatments
Center
19 sourcesNew Covid, better treatments: Weapons and tactics used for Omicron, variants to follow
COVID patients left with few treatment options after antibodies found ineffective against omicron
FDA halts use of antibody drugs they say don't work versus omicron
Current anti-COVID pills work well against omicron, but antibody drugs are less effective
Right
4 sourcesFDA Limits Use of Two COVID Antibody Treatments
FDA halts use of antibody drugs that don't work vs. omicron
FDA halts use of antibody drugs that don't work against omicron
FDA limits monoclonal antibody treatments shown to be ineffective against omicron
The story so far
2 developments- Jan 24, 2022FDA restricts use of certain monoclonal antibody treatments that don't work against omicron
- Jan 26, 2022The FDA is restricting the use of 2 drugs first authorized to treat COVID
Who covered each development
No new developments
Quiet for 1725 daysLast development · Jan 26, 2022 — The FDA is restricting the use of 2 drugs first authorized to treat COVID